Exelixis (EXEL) Other Non-Current Liabilities (2010 - 2026)

Exelixis (EXEL) recorded quarterly Other Non-Current Liabilities of $117.3 million in Q2 2026, up 12.36% quarter-over-quarter from $104.4 million in Q1 2026, and down 2.22% on a YoY basis from $120.0 million in Q2 2025.

Exelixis (EXEL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Exelixis' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $117.3 million for Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities fell 2.22% year-over-year to $117.3 million; the TTM figure through Apr 2026 stood at $117.3 million (down 2.22% YoY), while the FY2026 annual figure was $104.4 million, down 4.11% from the prior year.
  • Other Non-Current Liabilities was $117.3 million for Q2 2026 at Exelixis, up from $104.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $128.6 million in Q3 2025 to a low of $1.9 million in Q3 2022.
  • Historically, Other Non-Current Liabilities has averaged $82.1 million across 5 years, with a median of $96.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities tumbled 53.35% in 2022, then soared 3129.35% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $68.5 million in 2022, then surged by 37.49% to $94.2 million in 2023, then rose by 1.95% to $96.1 million in 2024, then climbed by 17.22% to $112.6 million in 2025, then climbed by 4.19% to $117.3 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $117.3 million (Q2 2026), $104.4 million (Q1 2026), and $112.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 117.33 Mn
Jan 2, 2026 104.42 Mn
Oct 3, 2025 112.61 Mn
Jul 4, 2025 128.59 Mn
Apr 4, 2025 120.00 Mn
Jan 3, 2025 108.90 Mn
Sep 27, 2024 96.07 Mn
Jun 28, 2024 109.67 Mn
Mar 29, 2024 101.27 Mn
Dec 29, 2023 94.22 Mn
Sep 29, 2023 61.62 Mn
Jun 30, 2023 73.50 Mn
Mar 31, 2023 67.38 Mn
Dec 30, 2022 68.53 Mn
Sep 30, 2022 1.91 Mn
Jul 1, 2022 17.40 Mn
Apr 1, 2022 12.52 Mn
Dec 31, 2021 8.02 Mn
Oct 1, 2021 4.09 Mn
Jul 2, 2021 7.07 Mn